Skip to main navigation Skip to search Skip to main content

Amyloidosis Inhibition and Detection of Human Islet Amyloid Polypeptide with Nanomaterials

Research output: Chapter in Book/Report/Conference proceeding › Chapter (Book) › Research › peer-review

Abstract

Type 2 diabetes (T2D), a metabolic disorder that is associated with progressive β-cell failure, manifests as a decline in insulin secretion and increasing hyperglycemia. A growing body of evidence suggests that β-cell failure in T2D correlates with the formation of pancreatic islet amyloid deposits, indicating that islet amyloid may have an important role in β-cell loss in this disease. Islet amyloid polypeptide (IAPP; amylin), the major component of islet amyloid, is co-secreted with insulin from β-cells. The mechanism(s) responsible for islet amyloid formation in T2D is still unclear. Inhibitors of islet amyloid fibril formation might prevent the progression to β-cell failure in T2D and should therefore be considered as a therapeutic approach to treat this disease. In addition to the mitigation efforts, sensing and imaging of IAPP amyloidosis is another important research area central to the development of anti-T2D theranostics.
Original languageEnglish
Title of host publicationRSC Nanoscience and Nanotechnology
EditorsAmar Abderrahmani, Sabine Szunerits, Rabah Boukerroub, Abdelfattah El Ouaamari
Place of PublicationUnited Kingdom
PublisherThe Royal Society of Chemistry
Chapter4
Pages113-127
Number of pages15
Volume59
ISBN (Electronic)9781839165498, 9781839165504
ISBN (Print)9781839164705
DOIs
Publication statusPublished - 2023

Publication series

NameRSC Nanoscience and Nanotechnology
Volume59
ISSN (Print)1757-7136
ISSN (Electronic)1757-7144

Cite this